Remedywear™ (TENCEL + Zinc) Hypoallergenic Bra - Light Support
Remedywear™ (TENCEL + Zinc) Hypoallergenic Bra - Light Support
Model wearing a white Remedywear bra as an eczema bra line treatment.
Back of model wearing a white Remedywear bra for eczema.
Front of a black Remedywear bra on a model.

YoRo Naturals

Remedywear™ (TENCEL + Zinc) Hypoallergenic Bra - Light Support

Sale price$49.99
Color:White
Size:XSmall
Quantity:

Hypoallergenic Bras with Smartcel Sensitive

Remedywear™'s hypoallergenic bras are made without latex, nylon or nickel and use only allergy safe dyes to ensure lasting comfort without irritation. The bralette shape provides basic support without annoying underwire and provides great relief for bra line eczema, nipple eczema and skin allergies. Works great overnight or during the day under clothing for treating sensitive skin, eczema and psoriasis in the bra area. Wear these comfort bras along with your favorite natural eczema cream for added relief.

  • Offers light support - not a sports bra.
  • Fabric lined, latex free elastic band at bra line.
  • Double layer coverage in front.
  • Stretchy and form-fitting.
  • Moisture-wicking sweat control.

See the full line of Remedywear for babies to adults here.

What Makes Remedywear Unique

  • 100% Satisfaction Guarantee or your money back within 30 days.
  • Dermatologist Recommended.
  • Contains soothing, moisture wicking TENCEL.
  • Contains anti-bacterial, anti-odor, anti-microbial, anti-inflammatory Zinc Oxide.
  • Fibers improve sleep quality and itchy skin when worn consecutively for three nights[1].
  • Moisture-wicking sweat control.
  • Stretchy, snug second skin fit.
  • Wear under clothing for all day relief or alone at nighttime.
  • Hypoallergenic, latex-free elastane.
  • Oeko-tex standard 100 and Step by Oeko-tex.
  • Eco-friendly packaging and tags.
  • Sustainably made in Portugal.

References:

[1] Wiegand, 2013, Skin-protective effects of a zinc oxide-functionalized textile and its relevance for atopic dermatitis. Clin Cosmet Investig Dermatol; 6: 115–121.